G20
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All participants must have a diagnosis of idiopathic Parkinson’s disease according to the UK Brain Bank criteria and present with moderate disease severity (Hoehn and Yahr stages 2.0–3.0). Individuals of all sexes are eligible. Participants must be able to provide written informed consent. Cognitive capacity to understand study procedures and to provide informed consent is confirmed by a licensed psychologist prior to study entry.
Exclusion criteria
Exclusion criteria: Participants are excluded if they are unable to provide written informed consent due to cognitive, psychological, or physical limitations. Individuals who demonstrate insufficient motivation or inability to comply with study procedures are excluded. Participants with known comorbid medical or neurological conditions that may interfere with safe participation or outcome assessment are also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is change in gait performance and balance from baseline to post-intervention (8 weeks). Measurements are performed before and after the intervention period by the investigator using the Timed Up and Go Test, Five Times Sit-to-Stand Test (5xSTS), and a static balance test. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome is change in emotional state from baseline to post-intervention (8 weeks). Emotional status is assessed before and after the intervention period by the investigator using the Estonian standardized questionnaire EEK-2. | — |
Countries
Estonia
Contacts
Tallinn University, School of Natural Sciences and Health